1 Wong SL, "The effect of prior breast biopsy method and concurrent definitive breast procedure on success and accuracy of sentinel lymph node biopsy" 9 : 272-277, 2002
2 Krag DN, "Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically nodenegative breast cancer: results from the NSABP B-32 randomised phase III trial" 8 : 881-888, 2007
3 Ruano R, "Staging the axilla with selective sentinel node biopsy in patients with previous excision of non-palpable and palpable breast cancer" 35 : 1299-1304, 2008
4 Nos C, "Sentinel lymph node detection for breast cancer: which patients are best suited for the patent blue dye only method of identification?" 8 : 438-443, 2001
5 O’Hea BJ, "Sentinel lymph node biopsy in breast cancer: initial experience at Memorial Sloan-Kettering Cancer Center" 186 : 423-427, 1998
6 McMasters KM, "Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used" 18 : 2560-2566, 2000
7 Hung WK, "Randomized clinical trial comparing blue dye with combined dye and isotope for sentinel lymph node biopsy in breast cancer" 92 : 1494-1497, 2005
8 Rutgers EJ, "Quality control in the locoregional treatment of breast cancer" 37 : 447-453, 2001
9 Tafra L, "Multicenter trial of sentinel node biopsy for breast cancer using both technetium sulfur colloid and isosulfan blue dye" 233 : 51-59, 2001
10 Chen SL, "Lymphatic mapping and sentinel node analysis: current concepts and applications" 56 : 292-309, 2006
1 Wong SL, "The effect of prior breast biopsy method and concurrent definitive breast procedure on success and accuracy of sentinel lymph node biopsy" 9 : 272-277, 2002
2 Krag DN, "Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically nodenegative breast cancer: results from the NSABP B-32 randomised phase III trial" 8 : 881-888, 2007
3 Ruano R, "Staging the axilla with selective sentinel node biopsy in patients with previous excision of non-palpable and palpable breast cancer" 35 : 1299-1304, 2008
4 Nos C, "Sentinel lymph node detection for breast cancer: which patients are best suited for the patent blue dye only method of identification?" 8 : 438-443, 2001
5 O’Hea BJ, "Sentinel lymph node biopsy in breast cancer: initial experience at Memorial Sloan-Kettering Cancer Center" 186 : 423-427, 1998
6 McMasters KM, "Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used" 18 : 2560-2566, 2000
7 Hung WK, "Randomized clinical trial comparing blue dye with combined dye and isotope for sentinel lymph node biopsy in breast cancer" 92 : 1494-1497, 2005
8 Rutgers EJ, "Quality control in the locoregional treatment of breast cancer" 37 : 447-453, 2001
9 Tafra L, "Multicenter trial of sentinel node biopsy for breast cancer using both technetium sulfur colloid and isosulfan blue dye" 233 : 51-59, 2001
10 Chen SL, "Lymphatic mapping and sentinel node analysis: current concepts and applications" 56 : 292-309, 2006
11 Feldman SM, "Limitation in gamma probe localization of the sentinel node in breast cancer patients with large excisional biopsy" 188 : 248-254, 1999
12 Estourgie SH, "Excision biopsy of breast lesions changes the pattern of lymphatic drainage" 94 : 1088-1091, 2007
13 Cody HS 3rd, "Complementarity of blue dye and isotope in sentinel node localization for breast cancer: univariate and multivariate analysis of 966 procedures" 8 : 13-19, 2001
14 Varghese P, "Carpenter R. Methylene blue dye--a safe and effective alternative for sentinel lymph node localization" 14 : 61-67, 2008
15 Greenlee RT, "Cancer statistics, 2000" 50 : 7-33, 2000
16 Sakorafas GH, "Breast cancer surgery: historical evolution, current status and future perspectives" 40 : 5-18, 2001
17 Greco M, "Breast cancer patients treated without axillary surgery: clinical implications and biologic analysis" 232 : 1-7, 2000
18 Chagpar AB, "Biopsy type does not influence sentinel lymph node status" 190 : 551-556, 2005
19 Haigh PI, "Biopsy method and excision volume do not affect success rate of subsequent sentinel lymph node dissection in breast cancer" 7 : 21-27, 2000
20 Derossis AM, "A trend analysis of the relative value of blue dye and isotope localization in 2,000 consecutive cases of sentinel node biopsy for breast cancer" 193 : 473-478, 2001
21 Blessing WD, "A comparison of methylene blue and lymphazurin in breast cancer sentinel node mapping" 184 : 341-345, 2002